4//SEC Filing
Bronstein Ben 4
Accession 0000950170-24-069885
CIK 0001341235other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:12 PM ET
Size
10.1 KB
Accession
0000950170-24-069885
Insider Transaction Report
Form 4
Bronstein Ben
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-04+2,778→ 2,778 totalExercise: $4.09Exp: 2034-06-03→ Common Stock (2,778 underlying) - Award
Stock Option (Right to Buy)
2024-06-04+40,282→ 40,282 totalExercise: $4.09Exp: 2034-06-03→ Common Stock (40,282 underlying) - Award
Stock Option (Right to Buy)
2024-06-04+2,604→ 2,604 totalExercise: $4.09Exp: 2034-06-03→ Common Stock (2,604 underlying)
Footnotes (3)
- [F1]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
- [F2]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.
- [F3]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.
Documents
Issuer
Aldeyra Therapeutics, Inc.
CIK 0001341235
Entity typeother
Related Parties
1- filerCIK 0001604458
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 4:12 PM ET
- Size
- 10.1 KB